Trial · NCT07888972
Digital Health Literacy and Diabetes Management in Type 2 Diabetes
NCT07888972, Not yet recruiting, Abant Izzet Baysal University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Digital Health Literacy and Diabetes Management in Type 2 Diabetes. Trials, record NCT07888972. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888972
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Digital Health Literacy and Diabetes Management in Type 2 Diabetes
- NCT number
- NCT07888972
- Status
- Not yet recruiting
- Enrollment
- 348 participants, estimated
- Lead sponsor
- Abant Izzet Baysal University
- Conditions
- Type 2 Diabetes
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Digital Health Literacy Instrument (DHLI) | At study enrollment. | Digital health literacy will be assessed using the Digital Health Literacy Instrument (DHLI). The instrument measures participants' ability to access, understand, evaluate, and use health-related information obtained through digital technologies. The DHLI score will be calculated according to the scoring guidelines of the version used in the study. Higher scores indicate higher digital health literacy, according to the instrument's scoring method. |
| Secondary | Diabetes Self-Management Questionnaire (DSMQ) | At study enrollment. | Diabetes self-management will be assessed using the Diabetes Self-Management Questionnaire (DSMQ). The questionnaire evaluates diabetes-related self-management behaviors. Scores will be calculated according to the instrument's scoring guidelines, with higher scores indicating more effective diabetes self-management, as defined by the instrument. |
| Secondary | Diabetes Distress Scale (DDS) | At study enrollment. | Diabetes-related distress will be assessed using the Diabetes Distress Scale (DDS). The scale measures emotional distress associated with living with and managing diabetes. Scores will be calculated according to the instrument's scoring guidelines, with higher scores indicating greater diabetes distress. |
| Secondary | HbA1c Levels | At study enrollment. | Glycemic control will be assessed using glycated hemoglobin (HbA1c) levels, expressed as a percentage (%). HbA1c reflects average blood glucose levels over approximately the preceding 2-3 months and is an important clinical indicator for evaluating long-term glycemic control in individuals with type 2 diabetes mellitus. HbA1c values will be examined in relation to digital health literacy, diabetes distress, and diabetes self-management. The analysis will also consider relevant sociodemographic and clinical variables to assess whether digital health literacy is associated with HbA1c levels independently of these factors. Higher HbA1c levels generally indicate poorer glycemic control. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888972
GET https://conductscience.org/api/trials/v1/NCT07888972/registered